Download PDF
Thromb Haemost 2009; 101(01): 209-212
DOI: 10.1160/TH08-04-0224
Letters to the Editor
Schattauer GmbH

Low absolute risk of venous and arterial thrombosis in hyperhomocysteinaemia – A prospective family cohort study in asymptomatic subjects

Anja B. U. Mäkelburg
1   Division of Haemostasis, Thrombosis and Rheology, Department of Haematology, University Medical Centre Groningen, Groningen, The Netherlands
,
Willem M. Lijfering
1   Division of Haemostasis, Thrombosis and Rheology, Department of Haematology, University Medical Centre Groningen, Groningen, The Netherlands
,
Saskia Middeldorp
2   Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands
,
Karly Hamulyák
3   Department of Haematology, University Hospital Maastricht, Maastricht, The Netherlands
,
Nic J. G. M. Veeger
1   Division of Haemostasis, Thrombosis and Rheology, Department of Haematology, University Medical Centre Groningen, Groningen, The Netherlands
,
Martin H. Prins
4   Department of Clinical Epidemiology and Medical Technology Assessment, University Hospital Maastricht, Maastricht, The Netherlands.
,
Harry R. Büller
2   Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands
,
Jan van der Meer
1   Division of Haemostasis, Thrombosis and Rheology, Department of Haematology, University Medical Centre Groningen, Groningen, The Netherlands
› Author AffiliationsFinancial support: By the Dutch Heart Foundation (Grant no: 99.187). The funder had no role in the design and conduct of the study, collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.
Further Information

Publication History

Received: 09 April 2008

Accepted after major revision: 24 October 2008

Publication Date:
23 November 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56: 111-128.
    PubMedGoogle Scholar
  • 2 The Homocysteine Studies Collaboration.. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. J Am Med Assoc 2002; 288: 2015-2022.
    CrossrefPubMedGoogle Scholar
  • 3 den Heijer M, Rosendaal FR, Blom HJ. et al. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost 1998; 80: 874-877.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Bonaa KH, Njolstad I, Ueland PM. et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006; 354: 1578-1588.
    CrossrefPubMedGoogle Scholar
  • 5 den Heijer M, Willems HP, Blom HJ. et al. Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial. Blood 2007; 109: 139-144.
    CrossrefPubMedGoogle Scholar
  • 6 Lonn E, Yusuf S, Arnold MJ. et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006; 354: 1567-1577.
    CrossrefPubMedGoogle Scholar
  • 7 Ray JG, Kearon C, Yi Q. et al. Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial. Ann Intern Med 2007; 146: 761-767.
    CrossrefPubMedGoogle Scholar
  • 8 Lijfering WM, Coppens M, van de Poel MH. et al. The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects. Thromb Haemost 2007; 98: 457-463.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 den Heijer M, Koster T, Blom HJ. et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334: 759-762.
    CrossrefPubMedGoogle Scholar
  • 10 Lijfering WM, Veeger NJ, Brouwer JL. et al. Methionine-loading and random homocysteine tests have no added value in risk assessment for venous and arterial thrombosis. J Thromb Haemost 2007; 05: 614-616.
    CrossrefPubMedGoogle Scholar
  • 11 Keijzer MB, Verhoef P, Borm GF. et al. No added value of the methionine loading task in assessment for venous thrombosis and cardiovascular disease risk. Thromb Haemost 2006; 95: 380-385.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Martinelli I, Bucciarelli P, Zighetti ML. et al. Low risk of thrombosis in family members of patients with hyperhomocysteinaemia. Br J Haematol 2002; 117: 709-711.
    CrossrefPubMedGoogle Scholar
  • 13 Nordstrom M, Lindblad B, Bergqvist D. et al. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992; 232: 155-160.
    CrossrefPubMedGoogle Scholar
  • 14 Vasan RS, Benjamin EV, Sullivan LM. et al. The Burden of Increasing Worldwide Cardiovascular Disease. In: Fuster V, O’Rourke RA, Walsh RA, Poole-Wilson P. editors. Hurst’s The Heart. New York: McGraw-Hill; Medical Pub. Division 2007
    Google Scholar
  • 15 Vaya A, Gomez I, Mira Y. et al. Homocysteine levels in patients with deep vein thrombosis lacking thrombophilic defects. Thromb Haemost 2008; 99: 1132-1134.
    Article in Thieme ConnectPubMedGoogle Scholar